Compositions And Methods For Treating Purpura

  • Published: Jul 18, 2017
  • Earliest Priority: Nov 16 2007
  • Family: 30
  • Cited Works: 0
  • Cited by: 0
  • Cites: 0
  • Additional Info:
Full-text?

The full document isn't yet available to us from the patent office, but we've found a related patent (family member) to use for our images and PDF.

Abstract

Embodiments of the present invention are directed to compositions and methods for the treatment of purpura. Preferred compositions comprise an a adrenergic receptor agonist selected from selective .alpha.1 adrenergic receptor agonist, selective .alpha.2 adrenergic receptor agonist, non-selective .alpha.1/.alpha.2 adrenergic receptor agonist, agents with .alpha.2 adrenergic receptor agonist activity and combinations thereof, in a pharmaceutically acceptable carrier in order to treat and improve the cosmetic appearance of hemorrhagic (purpuric) lesions in the skin.


Claims

Information currently unavailable.

Family Member PDF
Family Member Preview
These are the images from a related family member, as the full document isn't yet available to us from the patent office.
Document History
  • Publication: Jul 18, 2017
  • Application: Nov 17, 2008
    CA CA 2703109 A
  • Priority: Nov 17, 2008
    US US 2008/0083774 W
  • Priority: Nov 16, 2007
    US US 98856407 P

Sign in to the Lens

Feedback